The company, which makes joint replacements and medical implants used to repair broken bones, narrowed its forecast for adjusted annual profit to between $14.95 and $15.10 per share, from its prior range of $14.90 to $15.10 per share.
The company, which makes joint replacements and medical implants used to repair broken bones, narrowed its forecast for adjusted annual profit to between $14.95 and $15.10 per share, from its prior range of $14.90 to $15.10 per share.